Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?
IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
Insight into the mechanism of laquinimod action.
Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
From Bugs to Brains: the gut microbiome in neurological health
Chemical and Biological Therapeutic Approaches to Neurological Disorders III
Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis.
Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial.
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Masitinib is being investigated in the treatment of amyotrophic lateral sclerosis (ALS)
Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.
Gene Expression & Signaling in the Immune System
Genzyme provides update on U.S. LEMTRADA™ filing
Teva Pharmaceutical Industries Limited's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Autoimmunity in visual loss.
Reliable volumetry of the cervical spinal cord in MS patient follow-up data with cord image analyzer (Cordial).
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
Chemotherapeutics in the treatment of multiple sclerosis.
Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a ...
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
Extension CombiRx data show no benefit of combined MS drugs

Pages